HUS2000047I1 - Vakcina Lawsonia intracellularis elleni védelemre - Google Patents

Vakcina Lawsonia intracellularis elleni védelemre

Info

Publication number
HUS2000047I1
HUS2000047I1 HUS2000047C HUS2000047C HUS2000047I1 HU S2000047 I1 HUS2000047 I1 HU S2000047I1 HU S2000047 C HUS2000047 C HU S2000047C HU S2000047 C HUS2000047 C HU S2000047C HU S2000047 I1 HUS2000047 I1 HU S2000047I1
Authority
HU
Hungary
Prior art keywords
vaccine
protection against
lawsonia intracellularis
against lawsonia
intracellularis
Prior art date
Application number
HUS2000047C
Other languages
English (en)
Original Assignee
Intervet Int Bv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=41212183&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=HUS2000047(I1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Intervet Int Bv filed Critical Intervet Int Bv
Publication of HUS2000047I1 publication Critical patent/HUS2000047I1/hu

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/105—Delta proteobacteriales, e.g. Lawsonia; Epsilon proteobacteriales, e.g. campylobacter, helicobacter
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/12—Antidiarrhoeals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/54—Medicinal preparations containing antigens or antibodies characterised by the route of administration
    • A61K2039/541—Mucosal route
    • A61K2039/542—Mucosal route oral/gastrointestinal
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
    • A61K2039/552—Veterinary vaccine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A61K2039/55566—Emulsions, e.g. Freund's adjuvant, MF59

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Immunology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Epidemiology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Virology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
HUS2000047C 2008-04-18 2020-11-25 Vakcina Lawsonia intracellularis elleni védelemre HUS2000047I1 (hu)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP08154764 2008-04-18
EP08105738 2008-11-06
EP18154850.4A EP3351267B1 (en) 2008-04-18 2009-04-16 Vaccine for protection against lawsonia intracellularis

Publications (1)

Publication Number Publication Date
HUS2000047I1 true HUS2000047I1 (hu) 2020-12-28

Family

ID=41212183

Family Applications (2)

Application Number Title Priority Date Filing Date
HUE09753743A HUE038294T2 (hu) 2008-04-18 2009-04-16 Vakcina lawsonia intracellularis elleni védelemre
HUS2000047C HUS2000047I1 (hu) 2008-04-18 2020-11-25 Vakcina Lawsonia intracellularis elleni védelemre

Family Applications Before (1)

Application Number Title Priority Date Filing Date
HUE09753743A HUE038294T2 (hu) 2008-04-18 2009-04-16 Vakcina lawsonia intracellularis elleni védelemre

Country Status (13)

Country Link
US (3) US20110033496A1 (hu)
EP (3) EP3708186A1 (hu)
JP (2) JP6026106B2 (hu)
CN (1) CN102006883A (hu)
BR (1) BR122019000869B1 (hu)
CA (1) CA2717969C (hu)
DK (2) DK2268308T3 (hu)
ES (1) ES2666671T3 (hu)
FR (1) FR21C1002I1 (hu)
HU (2) HUE038294T2 (hu)
PL (2) PL2268308T3 (hu)
TW (1) TWI551295B (hu)
WO (1) WO2009144088A2 (hu)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TWI551295B (zh) * 2008-04-18 2016-10-01 英特威特國際股份有限公司 防備胞內勞森菌（Ｌａｗｓｏｎｉａ ｉｎｔｒａｃｅｌｌｕｌａｒｉｓ）用疫苗
ES2606131T3 (es) 2009-11-09 2017-03-22 Intervet International B.V. Método para cultivar bacterias Lawsonia intracellularis en células McCoy infectadas de forma persistente
KR101837768B1 (ko) 2011-05-25 2018-03-12 건국대학교 산학협력단 돼지 증식성 회장염을 진단하기 위한 단백질 및 그 응용
BR112016012435A8 (pt) 2013-12-03 2018-01-30 Intervet Int Bv vacina, e, usos de uma proteína orf2 recombinantemente expressada do circovírus porcino tipo 2
MX371126B (es) * 2013-12-03 2020-01-17 Intervet Int Bv Vacuna para cerdos contra el sindrome reproductivo y respiratorio porcino y lawsonia intracellularis.
JP6488304B2 (ja) 2013-12-03 2019-03-20 インターベット インターナショナル ベー． フェー． ローソニア・イントラセルラリス（ｌａｗｓｏｎｉａ ｉｎｔｒａｃｅｌｌｕｌａｒｉｓ）及びブタサーコウイルス（ｐｏｒｃｉｎｅ ｃｉｒｃｏｖｉｒｕｓ）２に対するワクチン
JP2018504423A (ja) * 2015-02-04 2018-02-15 インターベット インターナショナル ベー． フェー． 豚における無症候性ローソニア感染症に対する使用のためのワクチン
US10751405B2 (en) * 2015-02-04 2020-08-25 Intervet Inc. Vaccine for use against subclinical Lawsonia infection in a pig
HUE059657T2 (hu) * 2015-10-22 2022-12-28 Intervet Int Bv Vakcina MDA-pozitív állat védelmére Lawsonia Intracellularisszal történõ fertõzésbõl adódó betegség ellen
JP6655414B2 (ja) 2016-02-15 2020-02-26 株式会社デンソー 排気浄化システム
BR112020011044A2 (pt) 2017-12-04 2020-11-17 Intervet International B.V. vacinação com partículas de replicon e adjuvante de óleo
EP3727444A1 (en) 2017-12-18 2020-10-28 Intervet International B.V. Swine influenza a virus vaccine
MX2020008913A (es) * 2018-02-28 2020-10-01 Boehringer Ingelheim Vetmedica Gmbh Metodo para reducir el escatol y/o indol en animales.
CN115768785A (zh) 2020-06-19 2023-03-07 英特维特国际股份有限公司 包含含有编码病毒的不同神经氨酸酶抗原的第一、第二和第三核酸序列的核酸构建体的甲型猪流感病毒疫苗
EP4168428A1 (en) 2020-06-19 2023-04-26 Intervet International B.V. Swine influenza a virus vaccine comprising a nucleic acid construct encoding antigens of specific virus lineages
US20230277649A1 (en) 2020-06-19 2023-09-07 Intervet Inc. Swine influenza a virus vaccine comprising two distinct rna replicon particles
CN115768472A (zh) 2020-06-19 2023-03-07 英特维特国际股份有限公司 包含具有特定基因顺序的核酸构建体的甲型猪流感病毒疫苗
JP2024536600A (ja) 2021-10-25 2024-10-04 インターベット インターナショナル ベー． フェー． ブタａ型インフルエンザウイルス感染に対して子ブタを防御するためのワクチン
WO2023073640A1 (en) 2021-11-01 2023-05-04 Boehringer Ingelheim Vetmedica Gmbh Immunogenic gel compositions
WO2024068637A1 (en) 2022-09-27 2024-04-04 Intervet International B.V. A method of culturing lawsonia intracellularis bacteria

Family Cites Families (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0382271B1 (en) 1989-02-04 1994-12-21 Akzo Nobel N.V. Tocols as adjuvant in vaccine
FR2649012B1 (fr) 1989-07-03 1991-10-25 Seppic Sa Emulsions multiphasiques injectables
US5885823A (en) 1995-06-05 1999-03-23 Nobl Laboratories, Inc. Lawsonia intracellularis cultivation, anti-Lawsonia intracellularis vaccines and diagnostic agents
WO1997020050A1 (en) 1995-11-30 1997-06-05 Daratech Pty. Ltd. Therapeutic and diagnostic compositions
AU775323B2 (en) * 1999-05-13 2004-07-29 Agriculture Victoria Services Pty Ltd Lawsonia derived gene and related hemolysin polypeptides, peptides and proteins and their uses
EP1094070A3 (en) 1999-10-22 2002-01-09 Pfizer Products Inc. Lawsonia intracellularis proteins, and related methods and materials
JP2004529854A (ja) 2000-09-29 2004-09-30 アリゾナ・ボード・オブ・リージエンツ・オン・ビハーフ・オブ・ザ・ユニバーシテイー・オブ・アリゾナ 増殖性回腸炎のための改善されたワクチン及びその作製と使用の方法
EP1219711B1 (en) 2000-12-20 2006-06-14 Intervet International BV Lawsonia intracellularis vaccine
PL1651260T5 (pl) * 2003-07-25 2018-11-30 Boehringer Ingelheim Vetmedica, Inc. Lawsonia intracellularis pochodzenia europejskiego oraz szczepionki, środki diagnostyczne i sposoby ją wykorzystujące
WO2005070958A2 (en) 2004-01-22 2005-08-04 Intervet International B.V Lawsonia intracellularis subunit vaccines
KR20090051129A (ko) * 2004-04-05 2009-05-20 화이자 프로덕츠 인코포레이티드 미세유체화된 수중유 유화액 및 백신 조성물
EP2305294B1 (en) * 2004-09-22 2015-04-01 GlaxoSmithKline Biologicals SA Immunogenic composition for use in vaccination against staphylococcei
US20070212373A1 (en) 2004-12-08 2007-09-13 Akzo Nobel N.V. Lawsonia Intracellularis 26 Kd Subunit Vaccine
US8834891B2 (en) * 2005-03-14 2014-09-16 Boehringer Ingelheim Vetmedica, Inc. Immunogenic compositions comprising Lawsonia intracellularis
US8398994B2 (en) * 2005-07-15 2013-03-19 Boehringer Ingelheim Vetmedica, Inc. Lawsonia vaccine and methods of use thereof
PL1926496T3 (pl) 2005-09-09 2014-02-28 Intervet Int Bv Szczepionka przeciw PCV-2
WO2007103042A2 (en) 2006-03-03 2007-09-13 Merial Limited Mycoplasma hyopneumoniae vaccine
KR101541383B1 (ko) * 2006-03-30 2015-08-03 글락소스미스클라인 바이오로지칼즈 에스.에이. 면역원성 조성물
PL2007419T3 (pl) 2006-04-10 2012-09-28 Intervet Int Bv Szczepionka przeciwko mykoplazmie i PRRSV
US8470336B2 (en) * 2006-05-25 2013-06-25 Boehringer Ingelheim Vetmedica, Inc. Vaccination of young animals against Lawsonia intracellularis infections
WO2007138036A1 (en) 2006-05-30 2007-12-06 Intervet International B.V. Vaccine against rickettsia-like organisms
TWI449533B (zh) 2008-04-18 2014-08-21 Intervet Int Bv 防備胞內勞森菌（Ｌａｗｓｏｎｉａ ｉｎｔｒａｃｅｌｌｕｌａｒｉｓ）、豬肺炎黴漿菌（Ｍｙｃｏｐｌａｓｍａ ｈｙｏｐｎｅｕｍｏｎｉａｅ）及豬環狀病毒（Ｐｏｒｃｉｎｅ ｃｉｒｃｏ ｖｉｒｕｓ）用疫苗
TWI551295B (zh) * 2008-04-18 2016-10-01 英特威特國際股份有限公司 防備胞內勞森菌（Ｌａｗｓｏｎｉａ ｉｎｔｒａｃｅｌｌｕｌａｒｉｓ）用疫苗
US10751405B2 (en) 2015-02-04 2020-08-25 Intervet Inc. Vaccine for use against subclinical Lawsonia infection in a pig

Also Published As

Publication number Publication date
BRPI0909769A2 (pt) 2015-08-11
EP3708186A1 (en) 2020-09-16
DK2268308T3 (en) 2018-05-22
US20130302372A1 (en) 2013-11-14
EP2268308A2 (en) 2011-01-05
HUE038294T2 (hu) 2018-10-29
JP6138875B2 (ja) 2017-05-31
JP6026106B2 (ja) 2016-11-16
BR122019000869B1 (pt) 2023-11-07
EP3351267B1 (en) 2020-08-05
EP2268308B1 (en) 2018-03-14
CA2717969C (en) 2016-06-07
PL2268308T3 (pl) 2018-07-31
WO2009144088A3 (en) 2010-05-06
FR21C1002I1 (fr) 2021-03-05
WO2009144088A2 (en) 2009-12-03
US9198963B2 (en) 2015-12-01
US20110033496A1 (en) 2011-02-10
TW201002342A (en) 2010-01-16
JP2016026154A (ja) 2016-02-12
CA2717969A1 (en) 2009-12-03
EP3351267A1 (en) 2018-07-25
US20130045228A1 (en) 2013-02-21
US8597662B2 (en) 2013-12-03
ES2666671T3 (es) 2018-05-07
TWI551295B (zh) 2016-10-01
DK3351267T3 (da) 2020-09-21
CN102006883A (zh) 2011-04-06
JP2011516600A (ja) 2011-05-26
PL3351267T3 (pl) 2020-11-30

Similar Documents

Publication Publication Date Title
HUS2000047I1 (hu) Vakcina Lawsonia intracellularis elleni védelemre
HK1138853A1 (en) Vaccine
GB0717911D0 (en) Vaccine
ZA201004303B (en) Vaccine
GB0700135D0 (en) Vaccine
GB0711858D0 (en) Vaccine
PT2187958T (pt) Vacina atenuada de erliquiose
GB0810869D0 (en) Vaccine adjuvant composition
EP2252326A4 (en) VACCINE COMPOSITIONS
GB0805356D0 (en) Vaccine adjuvant composition
ZA201103645B (en) Single-time vaccines
GB0710538D0 (en) Vaccine
ZA201003851B (en) Vaccine
GB0801122D0 (en) Vaccine composition
HUE051465T2 (hu) Vakcina Lawsonia intracellularis elleni védelemre
GB0709373D0 (en) BCG-based anti-atheroma vaccine
GB0820404D0 (en) Vaccine compositions
GB0702363D0 (en) Vaccine composition
IL204404A (en) Weakened fever vaccine
GB0802326D0 (en) Vaccine Composition
GB0701262D0 (en) Vaccine
GB0700760D0 (en) Vaccine
GB0712062D0 (en) Vaccine
GB0706540D0 (en) Anti-atheroma vaccine
GB0713188D0 (en) Vaccine